A high cerebrospinal fluid soluble TREM2 level is associated with slow clinical progression of Alzheimer's disease

INTRODUCTION: The progression rate of Alzheimer's disease (AD) varies and might be affected by the triggering receptor expressed on myeloid cells (TREM2) activity. We explored if cerebrospinal fluid (CSF) soluble TREM2 (sTREM2), a proxy of microglial activity, is associated with clinical progre...

Descripción completa

Detalles Bibliográficos
Autores principales: Edwin, Trine Holt, Henjum, Kristi, Nilsson, Lars N.G., Watne, Leiv Otto, Persson, Karin, Eldholm, Rannveig Sakshaug, Saltvedt, Ingvild, Halaas, Nathalie Bodd, Selbæk, Geir, Engedal, Knut, Strand, Bjørn Heine, Knapskog, Anne‐Brita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Cerebrospinal Fluid Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720866/
https://www.ncbi.nlm.nih.gov/pubmed/33313376
http://dx.doi.org/10.1002/dad2.12128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720866/
https://www.ncbi.nlm.nih.gov/pubmed/33313376
http://dx.doi.org/10.1002/dad2.12128

Ejemplares similares